Division of Neurocritical Care
The faculty in the Division of Neurocritical Care are engaged in a variety of research projects that focus on acute brain injury and recovery. With research studies across the continuum of care, our faculty are at the forefront of discoveries in acute neurologic diseases such as seizure, stroke, subarachnoid hemorrhage and traumatic brain injury.
Examples of the types of research include clinical trials, discovery of new prognostic tools, advanced neuroimaging, genetics, electrophysiology and fundamental mechanisms of brain injury. Our unique and comprehensive portfolio of research is focused on questions that are directly relevant to the patients we treat in the NeuroICU, leading to state-of-the-art and impactful advances in the care of tomorrow’s patients.
The major areas of focus in acute brain injury include:
Our faculty’s research groups are located within several leading research centers at Mass General, including:
The Center for Genomic Medicine (CGM) is leading an effort to complete the genomic medicine cycle–from genetic discoveries to fundamental mechanisms of disease to new treatments for patients.
The Center for Neurotechnology and NeuroRecovery (CNTR) develops, tests and deploys novel neurotechnologies to improve the care of people with injuries or illness of the nervous system.
The Henry and Allison McCance Center for Brain Health at Mass General brings patients, clinicians and investigators together to prevent brain disease and preserve brain function across the lifespan.
Doctors from different disciplines together provide comprehensive care.
Find out more about research in the Department of Neurology, including clinical trials and our extensive portfolio of research labs.
